<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Hylete, Inc

    Hylete, Inc

    HYLETE is a fitness lifestyle brand, founded on the core belief that a company's i...

    HYLETE is a fitness lifestyle brand, founded on...

    Amount Raised:    $1,069,865.00
    Fundraising Status:    EC
    Filing Type:    PURACF
    Magellan Health, Inc.

    Magellan Health, Inc.

    Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest ...

    Magellan Health, Inc., a Fortune 500 company, i...

    Filing Type:    PU
    Venomyx, Inc

    Venomyx, Inc

    We're developing Vipax, the world's first portable, shelf-stable, broad-spectrum a...

    We're developing Vipax, the world's first porta...

    Amount Raised:    $290,122.00
    Fundraising Status:    EC
    Filing Type:    CF
    Immuron Limited

    Immuron Limited

    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on o...

    Immuron Ltd is a publicly listed Australian bio...

    Filing Type:    PU
    Sesen Bio, Inc.

    Sesen Bio, Inc.

    At Sesen Bio, we are committed to renewing life for people with cancer. We are a l...

    At Sesen Bio, we are committed to renewing life...

    Filing Type:    PU
    Correvio Pharma Corp.

    Correvio Pharma Corp.

    Correvio has two marketed, in-hospital, cardiology products: BRINAVESSÂŽ (vernakal...

    Correvio has two marketed, in-hospital, cardiol...

    Filing Type:    PU
    Sesen Bio, Inc.

    Sesen Bio, Inc.

    At Sesen Bio, we are committed to renewing life for people with cancer. We are a l...

    At Sesen Bio, we are committed to renewing life...

    Filing Type:    PU
    Stemline Therapeutics, Inc.

    Stemline Therapeutics, Inc.

    Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focuse...

    Stemline Therapeutics, Inc. is a commercial-sta...

    Filing Type:    PU
    Cyclacel Pharmaceuticals, Inc.

    Cyclacel Pharmaceuticals, Inc.

    Cyclacel's founding scientist, Professor Sir David Lane, a globally recognized aut...

    Cyclacel's founding scientist, Professor Sir Da...

    Filing Type:    PU
    Theravance Biopharma, Inc.

    Theravance Biopharma, Inc.

    Theravance Biopharma is a diversified biopharmaceutical company with the core purp...

    Theravance Biopharma is a diversified biopharma...

    Filing Type:    PU
    Kiniksa Pharmaceuticals, Ltd.

    Kiniksa Pharmaceuticals, Ltd.

    We are a biopharmaceutical company focused on discovering, acquiring, developing a...

    We are a biopharmaceutical company focused on d...

    Filing Type:    PU
    Immunic, Inc.

    Immunic, Inc.

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company develop...

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stag...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.